08:30–08:45 am | Intestinal epithelial stem cell tranplants improve acute and chronic stroke impairments
Farida Sohrabji (Bryan, USA)

08:45–09:00 am | Torpor is cerebroprotective after stroke
Eric Landsness (Saint Louis, USA)

09:00–09:15 am | Discovering new blood biomarkers of neuroplasticity associated to rehabilitation outcome after stroke
Anna Rosell (Barcelona, Spain)

09:15–09:30 am | Subacute cathodal transcranial direct current stimulation rescues secondary thalamic neurodegeneration after cortical stroke in mice
Stefan Blaschke (Cologne, Germany)

09:30–09:45 am | Inhibition of mGlu5 receptors in the contralateral somatosensory cortex enhances functional recovery after stroke
Tadeusz Wieloch (Lund, Sweden)

08:30–08:45 am | The effect of tocilizumab in animal models of ischaemic stroke: a systematic review and meta-analysis
Torsten Rackoll (Berliln, Germany)

08:45–09:00 am | Netrin-1 alleviates blood-brain barrier dysfunction via pericyte-microglia interaction after cerebral ischemia-reperfusion injury
Qiang Li (Shanghai, China)

09:00–09:15 am | Impact of anti-platelet and anti-coagulant therapies in a microfluidic model of thromboinflammation
Astride Perrot (Paris, France)

09:15–09:30 am | St3gal5-mediated glycosylation retains CD177+ neutrophils to restrict neuroinflammation in the acute injured brain
Tingting Huang (Shanghai, China)

09:30–09:45 am | PIWIL proteins and piRNAs may play a role in reducing neuroinflammation and stabilizing genomic integrity post-stroke
Rohan Patil (Naples, Italy)

08:30–08:45 am | Vectorization of Therapeutic Agents via Click Chemistry Mediated Grafting of the Finger Domain of TPA
Camille Delahaie (Caen, France)

08:45–09:00 am | Functionalization of antioxidant cerium oxide nanoparticles with DNase I to improve ischemic stroke treatment
Norhane Salah (Paris, France)

09:00–09:15 am | Network-based drug repurposing strategy for stroke treatment: A broad therapy for a specific patient
Ana Casas (Essen, Germany)

09:15–09:30 am | Optimization of Cell Penetrating Poly-Arginine Peptides to Provide a Superior Therapeutic Index Against Severe Excitotoxic Insults In Vitro
Joe Tauskela (Ottawa, Canada)

09:30–09:45 am | Development of therapeutic and diagnostic strategies targeting the neurovascular unit following exposure to organophosphorus nerve agents
Mélanie Lagadec (Caen, France)

10:15–10:30 am | 25HC dysregulates brain endothelial cell function and exacerbates spontaneous developmental cerebral haemorrhage
Victor Tapia (Manchester, UK)

10:30–10:45 am | A natural small-molecule targeting the NrF2/NLRP3 pathway shows beneficial effects in a zebrafish model of spontaneous intracerebral haemorrhage
Emily McMahon (Manchester, UK)

10:45–11:00 am | The dual neuroprotective and anti- inflammatory effects of acute Protein X administration in preclinical models of intracerebral haemorrhage
Chiara Ramponi (Manchester, UK)

11:00–11:15 am | Acute ACE-inhibitor treatment as a potential neuroprotective strategy after intracerebral haemorrhage
Paul Kasher (Manchester, UK)

11:15–11:45 am | discussion time